Deciphera Pharmaceuticals (DCPH) stock Forecast for 2021 – 2025

Deciphera Pharmaceuticals (DCPH) stock Forecast for 2022 – 2026

Last update: 05-23-2022, 6:40

Sector: Healthcare

The share price of Deciphera Pharmaceuticals, Inc. (DCPH) now

What analysts predict:: $10.78

52-week high/low: $38.91 / $6.51

50/200 Day Moving Average: $9.91 / $16.51

This figure corresponds to the average price over the previous 50/200 days. For Deciphera Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Deciphera Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Deciphera Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Deciphera Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Deciphera Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Deciphera Pharmaceuticals stock? When should I record a loss on Deciphera Pharmaceuticals stock? What are analysts' forecasts for Deciphera Pharmaceuticals stock? What is the future of Deciphera Pharmaceuticals stock?

We forecast Deciphera Pharmaceuticals stock performance using neural networks based on historical data on Deciphera Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Deciphera Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Deciphera Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Deciphera Pharmaceuticals stock

The chart below shows the historical price of Deciphera Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Deciphera Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Deciphera Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 25 12.51 12.00 12.79 6.59
May 26 12.35 12.01 12.80 6.56
May 27 12.54 12.20 13.00 6.56
May 28 12.45 12.05 12.60 4.54
May 29 12.11 11.85 12.42 4.84
May 30 12.43 12.26 12.66 3.23
May 31 12.26 11.82 12.46 5.36
Jun 01 11.95 11.81 12.40 5.01
Jun 02 11.60 11.27 11.72 4.02
Jun 03 11.68 11.51 12.07 4.91
Jun 04 11.46 11.11 11.82 6.41
Jun 05 11.75 11.49 12.14 5.68
Jun 06 11.64 11.23 12.12 7.92
Jun 07 11.43 11.23 11.74 4.53
Jun 08 11.60 11.25 12.06 7.20
Jun 09 11.39 11.12 11.78 5.91
Jun 10 11.66 11.48 11.86 3.24
Jun 11 11.75 11.54 12.24 6.05
Jun 12 11.21 10.79 11.43 5.95
Jun 13 11.16 10.73 11.36 5.89
Jun 14 10.86 10.68 11.21 4.97
Jun 15 10.47 10.35 10.73 3.67
Jun 16 10.95 10.78 11.40 5.69
Jun 17 11.19 10.98 11.54 5.10
Jun 18 11.23 10.88 11.70 7.55
Jun 19 11.18 10.87 11.51 5.88
Jun 20 11.27 11.10 11.45 3.07
Jun 21 11.41 11.06 11.86 7.21
Jun 22 11.18 10.80 11.63 7.68
Jun 23 10.89 10.76 11.04 2.62

Deciphera Pharmaceuticals Daily Price Targets


Deciphera Pharmaceuticals Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $12.51. Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 6.185%.

Pessimistic target level: 12.00

Optimistic target level: 12.79


Deciphera Pharmaceuticals Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $12.35. Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 6.157%.

Pessimistic target level: 12.01

Optimistic target level: 12.80


Deciphera Pharmaceuticals Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $12.54. Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 6.157%.

Pessimistic target level: 12.20

Optimistic target level: 13.00


Deciphera Pharmaceuticals Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $12.45. Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.347%.

Pessimistic target level: 12.05

Optimistic target level: 12.60


Deciphera Pharmaceuticals Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $12.11. Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.613%.

Pessimistic target level: 11.85

Optimistic target level: 12.42


Deciphera Pharmaceuticals Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $12.43. Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 3.132%.

Pessimistic target level: 12.26

Optimistic target level: 12.66


DCPH (DCPH) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 12.17 10.56 13.49 21.66
Jul. 12.32 11.65 13.55 14.00
Aug. 11.55 10.38 12.34 15.92
Sep. 10.01 9.31 10.93 14.84
Oct. 9.95 9.17 11.18 17.97
Nov. 9.49 8.56 10.55 18.88
Dec. 11.10 9.86 12.81 23.05

Deciphera Pharmaceuticals forecast for this year


Deciphera Pharmaceuticals Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $12.1715. Pessimistic: $10.56. Optimistic: $13.49


Deciphera Pharmaceuticals Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $12.3176. Pessimistic: $11.65. Optimistic: $13.55


Deciphera Pharmaceuticals Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $11.5539. Pessimistic: $10.38. Optimistic: $12.34


Deciphera Pharmaceuticals Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $10.0057. Pessimistic: $9.31. Optimistic: $10.93


Deciphera Pharmaceuticals Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $9.94563. Pessimistic: $9.17. Optimistic: $11.18


Deciphera Pharmaceuticals Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $9.48813. Pessimistic: $8.56. Optimistic: $10.55


Deciphera Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $11.1011. Pessimistic: $9.86. Optimistic: $12.81




Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 10.55 9.26 11.31 18.10
Feb 10.61 9.55 11.61 17.73
Mar 11.22 9.83 12.12 18.89
Apr 9.77 9.26 10.62 12.87
May 8.71 7.33 9.72 24.55
Jun 9.27 8.27 10.20 18.91
Jul 9.58 8.53 10.87 21.52
Aug 9.91 9.51 11.14 14.59
Sep 9.71 8.27 10.82 23.52
Oct 10.90 9.76 12.33 20.85
Nov 12.86 12.16 14.86 18.17
Dec 12.83 12.14 13.68 11.26

Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 12.88 11.77 14.94 21.21
Feb 12.11 10.85 13.76 21.13
Mar 12.98 11.06 14.33 22.83
Apr 13.97 13.21 15.14 12.73
May 14.44 13.46 15.37 12.41
Jun 15.14 13.99 16.56 15.54
Jul 14.11 12.10 15.41 21.43
Aug 14.90 13.08 15.73 16.86
Sep 12.45 11.71 13.48 13.12
Oct 10.59 9.59 11.86 19.11
Nov 9.51 8.69 10.48 17.06
Dec 9.28 8.57 10.61 19.23



Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 10.54 9.06 11.97 24.30
Feb 11.80 10.60 12.51 15.28
Mar 13.95 12.53 16.19 22.59
Apr 13.06 12.20 14.16 13.84
May 11.75 10.39 13.05 20.36
Jun 11.68 9.93 12.27 19.05
Jul 10.77 9.07 11.50 21.16
Aug 11.85 11.16 12.77 12.62
Sep 10.69 10.24 11.31 9.45
Oct 9.13 8.12 10.00 18.80
Nov 9.62 9.12 10.81 15.66
Dec 9.24 8.50 10.57 19.58

Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 10.92 9.39 11.57 18.87
Feb 11.88 10.02 12.61 20.53
Mar 13.94 13.05 14.72 11.36
Apr 14.81 13.65 16.94 19.41
May 15.13 14.14 16.50 14.31
Jun 17.77 16.70 20.26 17.54
Jul 18.41 16.35 20.65 20.86
Aug 19.14 16.16 20.83 22.43
Sep 18.72 17.41 19.73 11.76
Oct 17.75 14.94 19.03 21.46
Nov 14.98 12.88 16.81 23.35
Dec 11.98 10.62 13.69 22.42

Deciphera Pharmaceuticals information and performance

Deciphera Pharmaceuticals, Inc. is a clinical research biopharmaceutical company.

The company develops drugs designed to improve the lives of cancer patients. Her drug candidates include DCC-2618, DCC-3014 and (Rebastinib) Rebastinib. The platform of kinase switching inhibitors developed by the Company suppresses the process of kinase activation. DCC-2618 is an orally administered inhibitor of kinase switching control for the treatment of gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas including glioblastoma multiforme (GBM), and other solid tumors caused by the pan-KIT or PDGFR gene alpha. DCC-3014 is an orally administered potent and highly selective colony stimulating factor receptor 1 (CSF1R) inhibitor. Rebastinib is a potent and selective oral immunokinase inhibitor of TIE2. Rebastinib binds tightly to the binding region (pocket) of the TIE2 switch, stabilizing the inhibitory switch and displacing the activation switch to block TIE2 signaling.

Deciphera Pharmaceuticals Address

200 SMITH STREET, WALTHAM, MA, US

Market Capitalization: 784 003 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -131 316 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.898

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.162

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.95

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 66217000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.